Parathyroid hormone (Shire)

甲状旁腺素（Shire）

Report date: 2026/03/06 20:02:51

Base Information

Drug NameParathyroid hormone (Shire)
Drug Alias Name甲状旁腺激素（Shire）rhPTH-1-84 (Shire)EB612 (口服人甲状旁腺激素(1-34)）rhPTH (1-84) (Shire)Hormona paratiroidea (Shire) +[23] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionParathyroid hormone receptor agonistsOsteogenesis stimulantsCalcium sensing receptor antagonists +[4] 
TargetsCalcium sensing receptorParathyroid hormone receptor
Therapy Area/IndicationsPlaque psoriasisAutosomal Dominant Hypocalcemia Type 1Hypoparathyroidism +[8] 
Global Approved IndicationsHypoparathyroidismOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/04/24
Country/TerritoryBelgiumBulgariaCanada +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals International AG Ireland BranchGlaxosmithkline PlcNps Pharmaceuticals, Inc +[5] 
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)ShireNps Pharma Holdings Ltd +[7] 
Active IndicationsHypoparathyroidism
Inactive IndicationsPlaque psoriasisAutosomal Dominant Hypocalcemia Type 1Hyperparathyroidism +[7] 

Other Information

ATC CodeH05AA03
Related LinksWikipediaDrugBankKEGG